Figure 4.
Response of patient with non-Langerhans cell histiocytosis over 26 cycles of tazemetostat treatment. Black-outlined arrow denotes the lesion. Percent decrease was calculated by 2-dimensional measurements.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.